Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries

View ORCID ProfileMaria Elena Romero-Ibarguengoitia, View ORCID ProfileArnulfo González-Cantú, View ORCID ProfileChiara Pozzi, View ORCID ProfileRiccardo Levi, View ORCID ProfileMaximiliano Mollura, Riccardo Sarti, Miguel Angel Sanz-Sánchez, Diego Rivera-Salinas, Yodira Guadalupe Hernández-Ruíz, Ana Gabriela Armendariz-Vázquez, Gerardo Francisco Del Rio-Parra, Irene Antonieta Barco-Flores, Rosalinda González-Facio, Elena Azzolini, Riccardo Barbieri, Alessandro Rodrigo de Azevedo Dias, Milton Henriques-Guimaraes Júnior, Alessandra Bastos-Borges, Cecilia Acciardi, Graciela Paez-Bo, View ORCID ProfileMauro Martins Teixeira, View ORCID ProfileMaria Rescigno
doi: https://doi.org/10.1101/2022.03.11.22272153
Maria Elena Romero-Ibarguengoitia
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
2Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Elena Romero-Ibarguengoitia
  • For correspondence: MROMEROI@novaservicios.com.mx maria.rescigno@hunimed.eu
Arnulfo González-Cantú
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
2Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Arnulfo González-Cantú
Chiara Pozzi
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chiara Pozzi
Riccardo Levi
3IRCCS Humanitas Clinical and Research Center, Rozzano, MI, Italy
4Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, MI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Riccardo Levi
Maximiliano Mollura
5Politecnico di Milano, Department of Electronic, Information and Bioengineering, MI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maximiliano Mollura
Riccardo Sarti
3IRCCS Humanitas Clinical and Research Center, Rozzano, MI, Italy
4Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, MI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Angel Sanz-Sánchez
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
2Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego Rivera-Salinas
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
2Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yodira Guadalupe Hernández-Ruíz
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
2Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Gabriela Armendariz-Vázquez
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
2Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerardo Francisco Del Rio-Parra
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
2Vicerrectoría de Ciencias de la Salud, Escuela de Medicina, Universidad de Monterrey, San Pedro Garza García, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Antonieta Barco-Flores
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosalinda González-Facio
1Research Department, Hospital Clínica Nova de Monterrey, San Nicolás de los Garza, Nuevo León, México
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Azzolini
3IRCCS Humanitas Clinical and Research Center, Rozzano, MI, Italy
4Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, MI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Riccardo Barbieri
5Politecnico di Milano, Department of Electronic, Information and Bioengineering, MI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandro Rodrigo de Azevedo Dias
6Health Department, Ternium Brazil, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milton Henriques-Guimaraes Júnior
7Research Department Fundação São Francisco Xavier, Minas Gerais, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandra Bastos-Borges
7Research Department Fundação São Francisco Xavier, Minas Gerais, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Acciardi
8Health Secretary, Unidad Hospitalaria San José, Campana, Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graciela Paez-Bo
9Laboratory Department, Hospital Interzonal General de Agudos San Felipe, San Nicolás de los Arroyos, Buenos Aires, Argentina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauro Martins Teixeira
10Biochemistry and Immunology Department, ICB, Universidad Federal de Minas Gerais, Minas Gerais, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mauro Martins Teixeira
Maria Rescigno
3IRCCS Humanitas Clinical and Research Center, Rozzano, MI, Italy
4Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, MI, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maria Rescigno
  • For correspondence: MROMEROI@novaservicios.com.mx maria.rescigno@hunimed.eu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Scarce information exists in relation to the comparison of seroconversion and adverse events following immunization (AEFI) with different SARS-CoV-2 vaccines. Our aim was to correlate the magnitude of the antibody response to vaccination with previous clinical conditions and AEFI.

Methods A multicentric comparative study where SARS-CoV-2 spike 1-2 IgG antibodies IgG titers were measured at baseline, 21-28 days after the first and second dose (when applicable) of the following vaccines: BNT162b2 mRNA, mRNA-1273, Gam-COVID-Vac, Coronavac, ChAdOx1-S, Ad5-nCoV and Ad26.COV2. Mixed model and Poisson generalized linear models were performed.

Results We recruited 1867 subjects [52 (SD 16.8) years old, 52% men]. All vaccines enhanced anti-S1 and anti-S2 IgG antibodies over time (p<0.01). The highest increase after the first and second dose was observed in mRNA-1273 (p<0.001). There was an effect of previous SARS-CoV-2 infection; and an interaction of age with SARS-CoV-2, Gam-COVID-Vac and ChAdOx1-S (p<0.01). There was a negative correlation of Severe or Systemic AEFI (AEs) of naïve SARS-CoV-2 subjects with age and sex (p<0.001); a positive interaction between the delta of antibodies with Gam-COVID-Vac (p=0.002). Coronavac, Gam-COVID-Vac and ChAdOx1-S had less AEs compared to BNT162b (p<0.01). mRNA-1273 had a higher number of AEFIs. The delta of the antibodies showed an association with AEFIs in previously infected individuals (p<0.001).

Conclusions The magnitude of seroconversion is predicted by age, vaccine type and SARS-CoV-2 exposure. AEs are correlated with age, sex, and vaccine type. The delta of the antibody response is positively correlated with AEs in patients previously exposed to SARS-CoV-2.

Registration number NCT05228912

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research was conducted using private funding from Techint Group of Companies.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee/local Institutional Review Board from the school of Medicine from Universidad de Monterrey gave ethical approval: Ref.:26022021-CN-1e-CI

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • This version of the manuscript has an update in affiliation of author Riccardo Sarti that should be: 3. IRCCS Humanitas Clinical and Research Center, Rozzano, MI, Italy. 4. Humanitas University, Department of Biomedical Sciences, Pieve Emanuele, MI, Italy.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

  • Abbreviations

    (AEFI)
    Adverse events following immunization
    (AEs)
    Severe adverse events
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted May 04, 2022.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries
    Maria Elena Romero-Ibarguengoitia, Arnulfo González-Cantú, Chiara Pozzi, Riccardo Levi, Maximiliano Mollura, Riccardo Sarti, Miguel Angel Sanz-Sánchez, Diego Rivera-Salinas, Yodira Guadalupe Hernández-Ruíz, Ana Gabriela Armendariz-Vázquez, Gerardo Francisco Del Rio-Parra, Irene Antonieta Barco-Flores, Rosalinda González-Facio, Elena Azzolini, Riccardo Barbieri, Alessandro Rodrigo de Azevedo Dias, Milton Henriques-Guimaraes Júnior, Alessandra Bastos-Borges, Cecilia Acciardi, Graciela Paez-Bo, Mauro Martins Teixeira, Maria Rescigno
    medRxiv 2022.03.11.22272153; doi: https://doi.org/10.1101/2022.03.11.22272153
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries
    Maria Elena Romero-Ibarguengoitia, Arnulfo González-Cantú, Chiara Pozzi, Riccardo Levi, Maximiliano Mollura, Riccardo Sarti, Miguel Angel Sanz-Sánchez, Diego Rivera-Salinas, Yodira Guadalupe Hernández-Ruíz, Ana Gabriela Armendariz-Vázquez, Gerardo Francisco Del Rio-Parra, Irene Antonieta Barco-Flores, Rosalinda González-Facio, Elena Azzolini, Riccardo Barbieri, Alessandro Rodrigo de Azevedo Dias, Milton Henriques-Guimaraes Júnior, Alessandra Bastos-Borges, Cecilia Acciardi, Graciela Paez-Bo, Mauro Martins Teixeira, Maria Rescigno
    medRxiv 2022.03.11.22272153; doi: https://doi.org/10.1101/2022.03.11.22272153

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (230)
    • Allergy and Immunology (507)
    • Anesthesia (111)
    • Cardiovascular Medicine (1256)
    • Dentistry and Oral Medicine (207)
    • Dermatology (148)
    • Emergency Medicine (283)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (537)
    • Epidemiology (10047)
    • Forensic Medicine (5)
    • Gastroenterology (500)
    • Genetic and Genomic Medicine (2481)
    • Geriatric Medicine (239)
    • Health Economics (482)
    • Health Informatics (1652)
    • Health Policy (756)
    • Health Systems and Quality Improvement (638)
    • Hematology (250)
    • HIV/AIDS (536)
    • Infectious Diseases (except HIV/AIDS) (11888)
    • Intensive Care and Critical Care Medicine (626)
    • Medical Education (255)
    • Medical Ethics (75)
    • Nephrology (269)
    • Neurology (2301)
    • Nursing (140)
    • Nutrition (354)
    • Obstetrics and Gynecology (458)
    • Occupational and Environmental Health (537)
    • Oncology (1257)
    • Ophthalmology (377)
    • Orthopedics (134)
    • Otolaryngology (226)
    • Pain Medicine (158)
    • Palliative Medicine (50)
    • Pathology (326)
    • Pediatrics (737)
    • Pharmacology and Therapeutics (315)
    • Primary Care Research (282)
    • Psychiatry and Clinical Psychology (2294)
    • Public and Global Health (4850)
    • Radiology and Imaging (846)
    • Rehabilitation Medicine and Physical Therapy (493)
    • Respiratory Medicine (654)
    • Rheumatology (288)
    • Sexual and Reproductive Health (241)
    • Sports Medicine (228)
    • Surgery (271)
    • Toxicology (44)
    • Transplantation (130)
    • Urology (100)